V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10078746 | 10057914 | 1.72 | 91.9 | null | 2020-10-02 | 2020-10-02 | Busulfan Oral | 02 | null | ERLOTINIB | 100686413 |
| 10100529 | 10057918 | 1.65 | 100 | null | 2021-11-15 | 2021-11-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101475996 |
| 10133733 | 10057923 | 1.65 | 77.5 | 03 | 2019-06-28 | 2019-07-03 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | TOPOTECAN | 101578948 |
| 10161155 | 10057933 | null | null | null | 2019-06-25 | 2019-08-06 | CHLORAMBUCIL + LOMUSTINE | null | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100136510 |
| 10161782 | 10057935 | 1.63 | 91.7 | Palliative (P) | 2017-06-07 | 2017-06-19 | AVELUMAB + AXITINIB | 99 | N | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 101686103 |
| 10167078 | 10057937 | 1.77 | 98.7 | 03 | null | 2018-02-27 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 2 | N | MITOMYCIN INTRAVESICULAR | 100442281 |
| 10172420 | 10057940 | null | null | 03 | 2019-02-01 | 2019-02-03 | Binimetinib + Encorafenib | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101338366 |
| 10175292 | 10057944 | null | null | null | 2015-03-07 | 2018-09-20 | LENALIDOMIDE + RITUXIMAB | 02 | null | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100834633 |
| 10178405 | 10057949 | 1.88 | 84 | null | 2019-02-18 | 2019-02-28 | Binimetinib + Encorafenib | 02 | null | DASATINIB | 101422423 |
| 10179413 | 10057952 | 1.7 | 106.7 | null | 2019-10-19 | 2020-03-04 | null | 2 | null | CISPLATIN + PEMETREXED | 101002447 |
| 10180673 | 10057954 | 0 | 70 | Disease modification (D) | 2017-06-19 | 2017-06-19 | null | N | N | CHLORAMBUCIL + RITUXIMAB | 100328458 |
| 10183908 | 10057958 | 1.69 | 69 | Adjuvant (A) | 2019-12-10 | 2019-12-15 | PEG INTERFERON | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100408669 |
| 10184510 | 10057960 | 1.71 | 90 | null | 2019-08-29 | 2020-01-28 | CAV | 02 | null | ICON8B TRIAL | 101551993 |
| 10187101 | 10057967 | 0 | 58.6 | Disease modification (D) | 2019-08-15 | 2020-03-08 | Dasatinib | 02 | N | ICON8B TRIAL | 100147820 |
| 10187755 | 10057970 | 1.77 | 0 | null | 2019-10-10 | 2021-05-26 | Docetaxel + nintedanib | 02 | null | PERTUZUMAB | 100890940 |
| 10187907 | 10057971 | 0 | 79.6 | Palliative (P) | null | 2019-10-06 | CYTARABINE + METHOTREXATE + RITUXIMAB | 02 | N | FLAIR TRIAL | 101610626 |
| 10188203 | 10057972 | 1.87 | 36.2 | null | 2022-04-08 | 2022-04-23 | Cytarabine HD + Rituximab | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101412489 |
| 10189543 | 10057975 | 1.57 | 75.5 | Palliative (P) | 2018-12-22 | 2019-01-16 | STAR TRIAL | N | N | LUTETIUM-177 | 101255944 |
| 10191663 | 10057976 | 1.84 | 77.5 | 03 | 2022-01-17 | 2022-03-12 | DHAP | 02 | N | CETUXIMAB + ENCORAFENIB | 101495544 |
| 10192741 | 10057978 | 1.81 | 108 | Curative (C) | null | 2019-12-03 | CHOP | 02 | null | PACLITAXEL + PERTUZUMAB + TRASTUZUMAB | 100290070 |
| 10192845 | 10057979 | 1.75 | 77.2 | Palliative (P) | 2017-04-22 | 2017-04-24 | EVEROLIMUS + EXEMESTANE | 02 | N | STAMPEDE TRIAL | 100356404 |
| 10193508 | 10057981 | 1.75 | 108.4 | Neo-adjuvant (N) | 2019-08-09 | 2019-08-10 | DOCETAXEL + TRASTUZUMAB | 2 | N | OCTREOTIDE | 100385003 |
| 10193984 | 10057982 | 1.75 | 78.5 | Palliative (P) | 2018-09-22 | 2018-09-22 | Ixazomib | 02 | N | CAPECITABINE + CARBOPLATIN | 100028567 |
| 10194595 | 10057983 | 0 | 61.85 | 03 | 2019-10-08 | 2019-10-08 | Gemcitabine + Treosulfan (iv) | N | N | PEMETREXED | 100647434 |
| 10197600 | 10057989 | 1.78 | 82 | null | 2021-05-04 | 2021-10-13 | EOX | 02 | null | BINIMETINIB + ENCORAFENIB | 101798709 |
| 10197747 | 10057990 | 1.49 | 42 | 03 | 2017-05-04 | 2017-07-24 | null | null | N | TRIAL | 100502834 |
| 10198234 | 10057992 | 1.62 | 99.8 | Neo-adjuvant (N) | 2022-04-23 | 2022-05-09 | Bevacizumab 7.5mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 101679278 |
| 10198801 | 10057993 | 1.57 | 79.6 | Not known (9) | 2017-08-31 | 2017-08-31 | GDP | N | null | RIBOCICLIB | 101515753 |
| 10200537 | 10057996 | 0 | 83.6 | null | 2018-09-01 | 2018-09-01 | FLAIR trial | 02 | null | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100823947 |
| 10202044 | 10057997 | 1.7 | 65.3 | null | 2016-11-24 | 2018-01-22 | PCV | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101073860 |
| 10203528 | 10057998 | 1.64 | 78 | null | 2018-06-14 | 2018-07-12 | THALIDOMIDE | 02 | null | CISPLATIN + PEMETREXED | 100896080 |
| 10203933 | 10057999 | 0 | 50.8 | Adjuvant (A) | 2022-04-15 | 2022-05-02 | Bevacizumab | 02 | N | PEG INTERFERON | 100432747 |
| 10203945 | 10058000 | 0 | 69.8 | Curative (C) | 2019-04-22 | 2019-04-29 | EOX | 02 | N | OXALIPLATIN + MDG | 100600789 |
| 10208849 | 10058007 | 1.87 | 0 | null | 2017-11-19 | 2018-02-19 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 02 | null | BEVACIZUMAB | 100114234 |
| 10209860 | 10058008 | 1.66 | 92 | null | 2019-12-10 | 2019-12-26 | Lomustine | 02 | null | BEAM | 101658124 |
| 10210083 | 10058009 | 1.77 | 80 | null | 2020-03-09 | 2020-03-16 | Cytarabine Low Dose | 02 | N | CYTARABINE | 100979590 |
| 10221779 | 10058022 | null | null | Curative (C) | 2020-01-21 | 2020-01-27 | Capecitabine (21days) + Carboplatin | N | N | ISATUXIMAB + POMALIDOMIDE | 101383053 |
| 10222950 | 10058023 | 0 | 73 | null | 2019-03-16 | 2019-03-16 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100535154 |
| 10226663 | 10058025 | 1.73 | 58.1 | null | 2021-10-21 | 2021-11-08 | null | 02 | null | MELPHALAN + THALIDOMIDE | 101699506 |
| 10227216 | 10058026 | 1.63 | 79.5 | null | 2021-04-12 | 2021-04-30 | ANAGRELIDE | Y | null | BEXAROTENE | 100398263 |
| 10228933 | 10058029 | 1.68 | 95 | Adjuvant (A) | null | 2019-10-22 | IDELALISIB + RITUXIMAB | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101397469 |
| 10232432 | 10058030 | 1.5 | 70.9 | 03 | 2019-11-08 | 2019-12-14 | Fulvestrant + Ribociclib | 2 | N | GEFITINIB | 101383605 |
| 10240488 | 10058034 | 1.77 | 75.2 | Curative (C) | 2019-08-27 | 2019-08-27 | Dasatinib | 02 | N | TRANSPLANT CAR-T CELLS – BREXUCABTAGENE AUTOLEUCEL (KTE-X19) + CYCLOPHOSPHAMIDE + FLUDARABINE | 101791713 |
| 10245092 | 10058037 | 1.77 | 66.7 | Curative (C) | null | 2016-04-26 | Cyclophos + Dex + Lenalidomide | N | N | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | 100537325 |
| 10251295 | 10058039 | 1.73 | 78.6 | null | 2020-03-16 | 2020-04-16 | R GCVP | 02 | N | CYTARABINE + METHOTREXATE + RITUXIMAB | 100189616 |
| 10257267 | 10058040 | 1.75 | 71.8 | null | 2019-01-26 | 2019-02-01 | Rucaparib | 02 | null | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 101351999 |
| 10257579 | 10058041 | 1.48 | 90 | 03 | 2020-02-13 | 2020-02-13 | null | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101654023 |
| 10258053 | 10058042 | null | null | Palliative (P) | 2021-07-15 | 2021-07-22 | Capecitabine + Mitomycin | 02 | N | PERTUZUMAB | 101354123 |
| 10266939 | 10058045 | 0 | 49.4 | Palliative (P) | 2020-09-14 | 2020-09-29 | null | 02 | N | ANAGRELIDE | 100297623 |
| 10273538 | 10058048 | 1.72 | null | Curative (C) | 2021-02-13 | 2021-02-27 | Fulvestrant + Palbociclib | 02 | null | RCD TRIAL | 100113346 |